We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Volume 32 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Information for clinicians and patients.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How to carry out a clinical trial to apply for a marketing authorisation, manage your authorisation and report safety issues.
Information for applicants in England about the outcome of the National Clinical Impact Awards 2022.
Guidance for health professionals on diagnoses, prevention and treatment of meningococcal disease.
A range of tests are available from the majority of PHE regional clinical microbiology laboratories.
Information for patients, healthcare professionals and developers of new medicines
Projects granted during 2014 that have a primary purpose of basic research into the endocrine system and metabolism.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B.
The Advisory Committee on Clinical Impact Awards (ACCIA) advises health ministers on the presentation of clinical impact awards to consultants working in the NHS. ACCIA is an advisory non-departmental public body, sponsored by the Department of Health and Social Care...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.